PlumCare focuses on leveraging real-world evidence (RWE) to enhance pediatric healthcare outcomes through the integration of genomic information. The company emphasizes the importance of capturing genomic data at birth, which they believe can facilitate early interventions and improve access to targeted treatments. Founded by experts in molecular genetics, PlumCare aims to drive the discovery and development of pediatric drugs by utilizing their RWE platform, which is designed to support better health outcomes through early detection and treatment.

The PlumCare RWE platform is built on the foundation of extensive experience in research, clinical, and commercial genomics. This platform is intended to streamline the process of identifying and implementing effective treatments for children, thereby addressing the unique challenges in pediatric medicine. By focusing on real-world data, PlumCare seeks to create a more efficient pathway for drug development, ultimately leading to improved health outcomes for families and children.

United States

Plumcare is a healthcare company that provides real-world data for drug discovery and development, as well as DNA insights to empower families in managing their health.

PlumCare

Company Details